Cervical carcinoma is the fourth most common malignancy,
and ranked seventh as a cause of cancer deaths in Hong Kong females;
it affects more than five hundred women, and causes the death of
about one hundred and fifty women each year. Most of these
can be prevented if Cervical Intraepithelial Neoplasia (CIN) can
be detected and treated appropriately. CIN does not give
rise to any symptoms, but is suspected when abnormal cells are
found on Pap smear.
Pap smear can reduce the incidence and mortality
of cervical carcinoma. The target population encompasses
all women from age twenty-five, or the time of commencing sexual
activity, until they reach sixty-five years of age. Nine
out of every ten smears will show entirely normal cells, and the
smear will be reported as negative. The remaining one will
be classified as abnormal, but it does not necessarily mean that
the woman has cancer. After two consecutive normal annual
smears, it is recommended to screen at three yearly intervals.
Colposcopy is a diagnostic tool to determine the
cause of abnormalities found in pap smears. It involves
examination of the uterine cervix and lower genital tract epithelium
under magnification; identification of potentially dyplastic or
cancerous areas, and performance of directed biopsies of abnormal
areas to enable a histological diagnosis. It is not painful
and has no side effects, and can detect cancer of the cervix at
an early stage.
Colposcopy is a common procedure.
It is ordered by Obstetric and Gynaecology Specialists after
a pap smear is done.
This procedure could be performed as a day case.
Only Obstetric and Gynaecology Specialists perform Colposcopy
in our hospital.
For appointment or inquiry with a specialist
Obstetrician / Gynaecologist, Please phone: (852)
2276 7888